Ohta Yuko, Tsuruya Kazuhiko, Fujii Koji, Tokumoto Masanori, Kanai Hidetoshi, Matsumura Kiyoshi, Tsuchihashi Takuya, Hirakata Hideki, Iida Mitsuo
Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Hypertens Res. 2007 Apr;30(4):295-300. doi: 10.1291/hypres.30.295.
For hypertensive patients with renal diseases (RD), strict blood pressure (BP) control has been recommended in recent hypertension guidelines, such as JNC VI, JNC 7, WHO/ISH 1999 and ESH-ESC 2003. We assessed the current status of BP control and the changes of BP control before and after the publication of these guidelines in 489 hypertensive patients with or without RD (age, 19-89 years, mean 59+/-13 years) who visited the hypertension and kidney outpatient clinic at Kyushu University Hospital. The clinical characteristics of RD and non-RD patients were assessed (RD patients: age, 20-89 years, mean 60+/-13 years, n=311; non-RD patients: age, 19-86 years, mean 58+/-13 years, n=178). In addition, we compared the BP control status in 2003 to that in 1996. In 2003, the BP in RD patients was 134+/-16/78+/-10 mmHg and that in non-RD patients was 138+/-12/83+/-9 mmHg. When strict BP control was defined as <130/80 mmHg, the frequency of strict BP control in RD patients was 28.9% in 2003. In addition, the BP levels of RD patients in 2003 were significantly lower than those in 1996 (134+/-16/78+/-10 mmHg vs. 141+/-17/85+/-10 mmHg, p<0.05 for both systolic blood pressure [SBP] and diastolic blood pressure [DBP]), and the frequency of strict BP control in RD patients was higher in 2003 than in 1996 (28.9% vs. 11.8%, p<0.01). The BP levels of non-RD patients in 2003 tended to be lower than those in 1996 (138+/-12/83+/-9 mmHg vs. 141+/-13/85+/-9 mmHg, n.s.). In 2003, angiotensin II receptor blockers (ARBs) were more frequently prescribed to RD patients than to non-RD patients. Furthermore, the use of ARBs was markedly increased in 2003 compared with 1996. In conclusion, in our outpatient clinic, BP levels in hypertensive patients with RD have improved in recent years, and were lower than those in hypertensive patients without RD, which may in part reflect the physicians' awareness of the importance of strict BP control in RD patients, as suggested by several recent hypertension guidelines.
对于患有肾脏疾病(RD)的高血压患者,近期的高血压指南(如美国国家联合委员会第六次报告、美国国家联合委员会第七次报告、1999年世界卫生组织/国际高血压学会以及2003年欧洲高血压学会/欧洲心脏病学会)均推荐进行严格的血压(BP)控制。我们评估了489例有或无RD的高血压患者(年龄19 - 89岁,平均59±13岁)的血压控制现状以及这些指南发布前后血压控制情况的变化,这些患者均前往九州大学医院的高血压与肾脏门诊就诊。我们评估了RD患者和非RD患者的临床特征(RD患者:年龄20 - 89岁,平均60±13岁,n = 311;非RD患者:年龄19 - 86岁,平均58±13岁,n = 178)。此外,我们比较了2003年和1996年的血压控制情况。2003年,RD患者的血压为134±16/78±10 mmHg,非RD患者的血压为138±12/83±9 mmHg。当将严格血压控制定义为<130/80 mmHg时,2003年RD患者严格血压控制的频率为28.9%。此外,2003年RD患者的血压水平显著低于1996年(134±16/78±10 mmHg对141±17/85±10 mmHg,收缩压[SBP]和舒张压[DBP]均p<0.05),并且2003年RD患者严格血压控制的频率高于1996年(28.9%对11.8%,p<0.01)。2003年非RD患者的血压水平相较于1996年有降低趋势(138±12/83±9 mmHg对141±13/85±9 mmHg,无统计学意义)。2003年,血管紧张素II受体阻滞剂(ARB)在RD患者中的处方频率高于非RD患者。此外,与1996年相比,2003年ARB的使用显著增加。总之,在我们的门诊中,近年来患有RD的高血压患者的血压水平有所改善,且低于无RD的高血压患者,这可能部分反映了医生对严格控制RD患者血压重要性的认识,正如近期一些高血压指南所建议的。